Sanjak M - Search Results

1

Dissociation between mechanical and myoelectrical manifestation of muscle fatigue in amyotrophic lateral sclerosis.

Sanjak M, Konopacki R, Capasso R, Roelke KA, Peper SM, Houdek AM, Waclawik A, Brooks BR. Sanjak M, et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Mar;5(1):26-32. doi: 10.1080/14660820310017551. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004. PMID: 15204021

2

Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: beta-2 adrenergic agonists.

Brooks BR, Juhasz-Poscine K, Waclawik A, Sanjak M, Belden D, Roelke K, Parnell J, Weasler C. Brooks BR, et al. Among authors: sanjak m. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1 Suppl 4:45-53; discussion 53-4. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000. PMID: 11466959 Review. No abstract available.

3

Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis.

Sanjak M, Brinkmann J, Belden DS, Roelke K, Waclawik A, Neville HE, Ringel SP, Murphy JR, Brooks BR. Sanjak M, et al. J Neurol Sci. 2001 Oct 15;191(1-2):55-9. doi: 10.1016/s0022-510x(01)00624-4. J Neurol Sci. 2001. PMID: 11676992 Clinical Trial.

4

Role of muscular exercise in amyotrophic lateral sclerosis.

Sanjak M, Reddan W, Brooks BR. Sanjak M, et al. Neurol Clin. 1987 May;5(2):251-68, vi. Neurol Clin. 1987. PMID: 11681402 Review.

5

Disease-modifying drug therapies.

Brooks BR, Sanjak M. Brooks BR, et al. Among authors: sanjak m. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5 Suppl 1:68-75. doi: 10.1080/17434470410019898. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004. PMID: 15512878 Clinical Trial. No abstract available.

6

Quality control of vital capacity as a primary outcome measure during phase III therapeutic clinical trial in amyotrophic lateral sclerosis.

Sanjak M, Salachas F, Frija-Orvoen E, Theys P, Hutchinson D, Verheijde J, Pianta T, Stewart H, Brooks BR, Meininger V, Douillet P; Xaliproden [SR57746A] ALS International Study Group. Sanjak M, et al. Amyotroph Lateral Scler. 2010 Aug;11(4):383-8. doi: 10.3109/17482960903486083. Amyotroph Lateral Scler. 2010. PMID: 20192884

7

Supported treadmill ambulation for amyotrophic lateral sclerosis: a pilot study.

Sanjak M, Bravver E, Bockenek WL, Norton HJ, Brooks BR. Sanjak M, et al. Arch Phys Med Rehabil. 2010 Dec;91(12):1920-9. doi: 10.1016/j.apmr.2010.08.009. Arch Phys Med Rehabil. 2010. PMID: 21112435

8

Six-Minute Walk Test as a Measure of Walking Capacity in Ambulatory Individuals With Amyotrophic Lateral Sclerosis.

Sanjak M, Langford V, Holsten S, Rozario N, Patterson CGM, Bravver E, Bockenek WL, Brooks BR. Sanjak M, et al. Arch Phys Med Rehabil. 2017 Nov;98(11):2301-2307. doi: 10.1016/j.apmr.2017.04.004. Epub 2017 Apr 30. Arch Phys Med Rehabil. 2017. PMID: 28465220

9

Design of clinical therapeutic trials in amyotrophic lateral sclerosis.

Brooks BR, Sufit RL, DePaul R, Tan YD, Sanjak M, Robbins J. Brooks BR, et al. Among authors: sanjak m. Adv Neurol. 1991;56:521-46. Adv Neurol. 1991. PMID: 1853781 Review. No abstract available.

10

Natural history of amyotrophic lateral sclerosis. Quantification of symptoms, signs, strength, and function.

Brooks BR, Shodis KA, Lewis DH, Rawling JD, Sanjak M, Belden DS, Hakim H, DeTan Y, Gaffney JM. Brooks BR, et al. Among authors: sanjak m. Adv Neurol. 1995;68:163-84. Adv Neurol. 1995. PMID: 8787228 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters